The HVIP+ Community Model

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Arkansas

About this trial

The present study will use an optimization randomized control trial design to test the preliminary efficacy of a Hospital-based Violence Intervention Program (HVIP) in Central Arkansas.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Be at least 18 years of age or older

Currently live in Central Arkansas

Currently being treated for a penetrating gun assault injury at a local hospital

Disqualifiers

Report any medical problems that would limit their ability to express thoughts and answer questions (i.e. active intoxication, developmental delays, dementia, psychosis, etc.)

Be currently under arrest or in police custody

Trial design

Design model

Factorial

Treatments tested in this trial

  • Brief Bedside

    Behavioral

    * Initial support (in-hospital or shortly after if discharged early) * Needs assessment * Resource Sheet of Vetted Partners

  • Peer Support

    Behavioral

    * Weekly Check-ins * Status Check (Personal/family; Health; Mental Health; Spiritual, etc.) * Encouragement/Motivation (Staying safe, Doing right, etc.) * In-Person Visits (Home, Rehab, etc.) * Peer Social/Skill-building Activities (Money management, Job interviewing, Computer literacy, Creative arts, Critical thinking film discussions, etc.)

  • Case Management + Voucher

    Behavioral

    * Service Plan \& Referrals * Service Check-in/Follow up with partners and participants * Navigation of Health Care and Social Service Follow up appointments * Transportation Assistance * Basic life skills for service provision (riding bus/public transportation, zoom, etc.) * Vouchers for Immediate Needs/Obstacles

  • SELF Group Therapy Sessions

    Behavioral

    * Virtual Bi-weekly Group Therapy * SELF Curriculum- Trauma Focused Cognitive Behavioral Therapy * Lead by Therapists and Community Peer Volunteers * One-on-one Introductory/Intake Orientations

Treatment groups

208 Participants
are divided into 8 treatment groups

8

Treatment groups

See each treatment group below.

Group A: BB, CM, GExperimental treatment 3 interventions
Group B: BB, CMExperimental treatment 2 interventions
Group C: BB, GExperimental treatment 2 interventions
Group D: BBExperimental treatment 1 intervention
Group E: ALLExperimental treatment 4 interventions
Group F: BB, PS, CMExperimental treatment 3 interventions
Group G: BB, PS, GExperimental treatment 3 interventions
Group H: BB, PSExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Change in Risky Firearm Behaviors

Composite measure uses items adapted from the Tulane University National Youth Study capturing frequency and severity of risky firearm-related behaviors (i.e. carriage, threats, etc.) (0=Never; 6=20+ Times)

Time frame
Baseline, 3-month, 6-month, 9-month, and 12 months

Secondary outcomes

1

Change in PTSD

The Posttraumatic Stress Disorder Checklist (PCL-5) is a 20-item self-report measure that assesses the 20 DSM-5 symptoms of PTSD (0=Not at all; 4=Extremely)

Time frame
Baseline, 3-month, 6-month, 9-month, and 12 months
2

Change in Anxiety

OASIS is a brief measure of overall anxiety severity and impairment. (0=No/None; 4=Constant/Extreme)

Time frame
Baseline, 3-month, 6-month, 9-month, and 12 months
3

Change in Depression

The PHQ-9 is a validated, self-reported tool used for screening, diagnosing, and measuring the severity of depression. (0= Not at all; 3=Nearly every day)

Time frame
Baseline, 3-month, 6-month, 9-month, and 12 months
4

Change in Feasibility and Acceptability of Intervention

Composite measure uses items adapted from the Feasibility of Intervention Measure (FIM) and Acceptability of Intervention Measure (AIM), four-item measures of implementation outcomes. (1= Completely disagree; 5= Completely Agree)

Time frame
3-month, 6-month, 9-month, and 12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Arkansas

Lead sponsor

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator